Skip to main content
. 2020 Oct 30;10:1583. doi: 10.3389/fonc.2020.01583

Figure 5.

Figure 5

Comparison of overall survival between patients receiving chemotherapy and those not receiving chemotherapy or unknown in the five age groups. (I, N) There were significant differences of overall survival in age group of 66–80 years with intermediate-risk RS (P = 0.031) and high-risk RS (P = 0.042). (E) Women >80 years with low-risk RS had worse overall survival when receiving chemotherapy than those not or unknown (P = 0.002). (J, O) Women aged >80 years with intermediate-risk and high-risk RS, chemotherapy also seemed to be harmful although the differences were not statistically significant (P > 0.05). (A–D, F–H, K–M) There were no significant difference in any other age groups (P > 0.05).